Catalyst Wire Dossier Catalyst Wire Dossier

Norepinephrine bitartrate (Levophed)

norepinephrine bitartrate · Baxter Healthcare Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Norepinephrine bitartrate (Levophed), covering 2022-06-02 to 2022-06-02. Get the full timeline:

Most recent: FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Baxter Healthcare Corporation)

See pricing